Indibulin

DB06169InvestigationalSmall molecule

Investigated for use/treatment in solid tumors.

Chemical structure of Indibulin
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in solid tumors.Curator reviewed
Formula / weight
C22H16ClN3O2 · 389.84 g/mol (avg)
Code names
D-24851 · ZIO-301

Resolves to

Compound
UNII80K4H2RB8PCAS204205-90-3ChEMBLCHEMBL49642
Structure
InChIKeySOLIIYNRSAWTSQ-UHFFFAOYSA-NSMILESClC1=CC=C(CN2C=C(C(=O)C(=O)NC3=CC=NC=C3)C3=CC=CC=C23)C=C1

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Indibulin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In